BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37748210)

  • 1. Can tumour budding change the future of pulmonary adenocarcinoma?
    Ciflik KB; Dogan HT; Dogan E; Ciflik BO; Kocer B; Karaoglanoglu N; Yekeler E
    Pathol Res Pract; 2023 Oct; 250():154808. PubMed ID: 37748210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
    Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
    BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of tumour budding in stomach cancers.
    Kucuk S
    Int J Clin Pract; 2021 Dec; 75(12):e14922. PubMed ID: 34580963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.
    Ulase D; Heckl S; Behrens HM; Krüger S; Röcken C
    Histopathology; 2020 Feb; 76(3):433-446. PubMed ID: 31538348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion?
    Zenger S; Gurbuz B; Can U; Erginoz E; Ozata IH; Yilmaz SP; Taskin OC; Peker O; Adsay V; Balik E; Bugra D
    Langenbecks Arch Surg; 2023 Mar; 408(1):127. PubMed ID: 36973561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tumour budding on adjuvant chemotherapy in colorectal cancer.
    Xie H; Zeng Z; Hou Y; Ye F; Cai T; Cai Y; Xiong L; Li W; Liu Z; Liang Z; Luo S; Zheng X; Huang L; Liu H; Kang L
    BJS Open; 2024 Jan; 8(1):. PubMed ID: 38190579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patients.
    Zlobec I; Dawson HE; Blank A; Bokhorst JM; Berger MD; Nagtegaal ID; Lugli A
    Eur J Cancer; 2020 May; 130():139-145. PubMed ID: 32200222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam.
    Dao TV; Nguyen CV; Nguyen QT; Vu HTN; Phung HT; Bui OT; Nguyen DK; Luong BV; Tran TV
    Cancer Control; 2020; 27(1):1073274820968883. PubMed ID: 33136444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage- and regression-grade independent prognostic information in intestinal-type gastric adenocarcinoma.
    Jesinghaus M; Herz AL; Kohlruss M; Silva M; Grass A; Lange S; Novotny A; Ott K; Schmidt T; Gaida M; Hapfelmeier A; Denkert C; Weichert W; Keller G
    J Pathol Clin Res; 2022 Sep; 8(5):448-457. PubMed ID: 35715937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness.
    Yamaguchi Y; Ishii G; Kojima M; Yoh K; Otsuka H; Otaki Y; Aokage K; Yanagi S; Nagai K; Nishiwaki Y; Ochiai A
    J Thorac Oncol; 2010 Sep; 5(9):1361-8. PubMed ID: 20631633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
    Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
    Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential key roles of tumour budding: a representative malignant pathological feature of non-small cell lung cancer and a sensitive indicator of prognosis.
    Qian L; Zhang J; Lu S; He X; Feng J; Shi J; Liu Y
    BMJ Open; 2022 Mar; 12(3):e054009. PubMed ID: 35361643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should a fourth category be added to the international tumor budding consensus conference tumor budding scoring system in colorectal adenocarcinomas?
    Secinti IE; Ozgur T; Gursoy D; Dede I
    APMIS; 2022 Sep; 130(9):560-567. PubMed ID: 35816469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
    Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
    Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.
    Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E
    Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
    Basile D; Broudin C; Emile JF; Falcoz A; Pagès F; Mineur L; Bennouna J; Louvet C; Artru P; Fratte S; Ghiringhelli F; André T; Derangère V; Vernerey D; Taieb J; Svrcek M;
    Ann Oncol; 2022 Jun; 33(6):628-637. PubMed ID: 35306156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma.
    Petrova E; Zielinski V; Bolm L; Schreiber C; Knief J; Thorns C; Bronsert P; Timme-Bronsert S; Bausch D; Perner S; Keck T; Wellner U
    Virchows Arch; 2020 Apr; 476(4):561-568. PubMed ID: 31786688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
    Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
    Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Significance of Tumor Budding and Immunohistochemical Axl Expression in Gallbladder Adenocarcinomas.
    Öz Ö; Argon A; Kebat T; Namlı Akıncı Ç; Özdemir Ö
    Balkan Med J; 2022 May; 39(3):199-208. PubMed ID: 35430785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of tumour budding in squamous cell carcinoma of the lung: a systematic review and meta-analysis.
    Wankhede D; Hofman P; Grover S
    Histopathology; 2023 Mar; 82(4):521-530. PubMed ID: 36217904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.